Screener
Aurinia Pharmaceuticals AUPH Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Segments
By geography
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Deferred tax assets, net | 178,935 | 176,194 |
| Finance right-of-use lease assets | 65,152 | 73,865 |
| Intangible assets, net | 3,378 | 3,761 |
| Operating right-of-use lease assets | 1,518 | 3,596 |
| Property and equipment, net | 1,862 | 2,111 |
| Other noncurrent assets | 93 | 93 |
| Total assets | $792,262 | $751,587 |
| LIABILITIES AND SHAREHOLDERS' EQUITY |
Item 1. Financial Statements.
FAQ
- What is Aurinia Pharmaceuticals's operating lease ROU assets?
- Aurinia Pharmaceuticals (AUPH) reported operating lease ROU assets of $1.52M in Q2 2026.
- How has Aurinia Pharmaceuticals's operating lease ROU assets changed year-over-year?
- Aurinia Pharmaceuticals's operating lease ROU assets decreased by 60.4% year-over-year, from $3.84M to $1.52M.
- What is the long-term trend for Aurinia Pharmaceuticals's operating lease ROU assets?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's operating lease ROU assets has grown at a -8.1% compound annual growth rate (CAGR), from $5.49M to $3.6M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Aurinia Pharmaceuticals's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude